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Surviving as a cancer survivor: 
A case report of radiation-induced autonomic dysfunction 
By Daphne Sy, MS3 & Mark Schauer, MD 
Case Presentation: 
 
        A 41 year-old woman presents to the ED with exertional shortness of 
breath, syncope, and chest pressure of increasing intensity for 2 days.  
        Her PMH includes DM type 2, morbid obesity, and Hodgkin lymphoma at 
age 21, which was treated with ABVD and mantle radiation.  Immediate 
complications included pericardial fibrosis requiring window surgery, and 
thyroid fibrosis requiring thyroidectomy.  Over the past five years, she was 
diagnosed with progressive pulmonary fibrosis of the R upper lobe. Last 
year, a Type 2 AV block with episodes of syncope prompted AV pacemaker 
placement.. 
        During admission, providers witnessed several sudden drops in BP 
(80s/40s) with reflex tachycardia (150s); these episodes would begin while the 
patient was lying still and resolved spontaneously within 15 minutes.   
        Upon review of records from an outside facility, a cardiac workup in April 
2016 included a TTE showing EF = 55-60%, amd heart catheterization 
showed mild coronary artery disease and minimally elevated pulmonary artery 
pressures.  Despite these findings, she was diagnosed with heart failure 
based on clinical symptoms and placed on daily furosemide. 
        During current admission, BNP and Troponin I x2 were negative.  CXR 
showed her heart size was at the upper borderline of normal; findings were 
stable since previous visit.  NM stress test and cardiac MRI were both 
unremarkable. 
        A review of the long-term outcomes of Hodgkin lymphoma survivors 
established that many patients continue to develop fibrotic sequelae from 
chemoradiation, even two or more decades after their last treatment. Case 
reports described other survivors with similar symptoms.  Recently, 
autonomic dysregulation independent of cardiac factors was shown in 
both resting and exercising heart rates, increasing in direct correlation with 
the number of years since therapy. 
Background: 
 
        While radiation and chemotherapy have achieved 
high rates of cure for Hodgkin lymphoma, the 
medical community is only now starting to characterize 
the long-term effects of chemoradiation on young 
survivors of cancers. New constellations of adverse 
effects continue to develop even decades later, raising 
questions:  
 
Figure 1. Data on survivorship derived from The German, Swiss and Austrian 
Society of Paediatric Oncology and Haematology. From http://
www.forschenheiltkrebs.eu/ 
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Figure 3. A diagram of the 
distribution of typical mantle 
radiation, which was part of 
standard of treatment for Hodgkin 
lymphoma in 1990s  This allows 
us to anticipate organs of 
possible involvement or future 
concern. 3 
Figure 2. Increased rates of HR abnormalities among Hodgkin lymphoma survivors 
treated with thoracic radiation; radiation dosage did not cause a statistical difference 
(n = 263).2 
v   Should long-term follow up of cancer survivors be 
limited to five years with their oncologist? 
v  Is there enough need for “survivorship clinics” 
devoted to the surveillance concerns of former 
cancer patients?  
v  Should we train more PCPs who specialize in the 
unique risks of cancer survivors? 
	
Conclusions: 
 
v  Hodgkin lymphoma survivors have many unique 
health concerns, such as increased rates of cancer, 
progressive fibrosis of thoracic and neck organs, 
and increased rates of cancers (e.g. esophageal). 
v  Anticipating these effects allows us to screen these 
patients effectively and avoid repetitive expensive 
workups. 
v  Current screening tests for autonomic dysfunction 
are currently too expensive/high burden for wider 
use; however, screening for cancers and fibrosis 
may be beneficial. 
v  Effective treatment has not been described. 
                 *Optimize intravascular volume 
                 *No effective drugs for fibrosis 
v There are many directions open to future research. 
